A Multipronged Intervention to Reduce Readmissions and Readmission Intensity After Radical Cystectomy.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 01 05 2023
revised: 15 08 2023
accepted: 16 08 2023
medline: 11 12 2023
pubmed: 5 9 2023
entrez: 4 9 2023
Statut: ppublish

Résumé

To develop a multipronged, evidence-based protocol to reduce readmission risk and readmission intensity, as represented by the duration of the index readmission, after radical cystectomy. A per-protocol study was performed. The protocol included preoperative nutritional supplementation, early stent removal, and a follow-up phone call within 4-5days of discharge. The preprotocol period was from February 1, 2020 to July 31, 2021 and the postprotocol period was from December 1, 2020 to November 31, 2021. Using multivariate regression models, we compared outcomes among patients treated with radical cystectomy before and after protocol initiation. We identified 70 preprotocol patients and 126 postprotocol patients. After adjusting for age, sex, BMI, and frailty score, there was a significant reduction in 90-day readmission intensity (7 vs 5days; P = .048) among postprotocol patients. After implementation of an evidence-based protocol for patients undergoing radical 90-day readmission intensity decreased significantly. This protocol may move the needle forward on reducing readmissions, but a larger randomized trial is needed.

Identifiants

pubmed: 37666330
pii: S0090-4295(23)00732-X
doi: 10.1016/j.urology.2023.08.012
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

155-160

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Zeynep G Gul (ZG)

Univserity of Washington in St. Louis, Department of Surgery, Division of Urology, St. Louis, MO. Electronic address: gulz@wustl.edu.

Shan Wu (S)

University of Pittsburgh, Department of Urology, Pittsburgh, PA.

Michael Raver (M)

University of Pittsburgh, School of Medicine, Pittsburgh, PA.

Robin Vasan (R)

University of Pittsburgh, Department of Urology, Pittsburgh, PA.

Jennifer Mihalo (J)

University of Pittsburgh, School of Medicine, Pittsburgh, PA.

John M Myrga (JM)

University of Pittsburgh, Department of Urology, Pittsburgh, PA.

David T Miller (DT)

University of Pittsburgh, Department of Urology, Pittsburgh, PA.

Maria P Pere (MP)

University of Pittsburgh, Department of Urology, Pittsburgh, PA.

Cameron A Jones (CA)

University of Pittsburgh, Department of Urology, Pittsburgh, PA.

Danielle R Sharbaugh (DR)

University of Pittsburgh, Department of Urology, Pittsburgh, PA.

Jonathan G Yabes (JG)

University of Pittsburgh, School of Medicine, Pittsburgh, PA.

Bruce L Jacobs (BL)

University of Pittsburgh, Department of Urology, Pittsburgh, PA.

Benjamin J Davies (BJ)

University of Pittsburgh, Department of Urology, Pittsburgh, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH